Ablative therapies for colorectal liver metastases: A systematic review

Colorectal Disease

Volumn 13, Issue 9, 2011, Pages

  Pathak, Samir ^a   Jones, R ^a,b   Tang, J M F ^b   Parmar, C ^a   Fenwick, S ^a   Malik, H ^a   Poston, G ^a  

^a ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Ablative therapies; Colorectal liver metastases

Indexed keywords

ABLATION THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL CANCER; COLORECTAL LIVER METASTASIS; CRYOABLATION; FOLLOW UP; HUMAN; LIVER METASTASIS; MICROWAVE THERAPY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW;

ADENOCARCINOMA; CATHETER ABLATION; COLORECTAL NEOPLASMS; CRYOSURGERY; HUMANS; LIVER NEOPLASMS; MICROWAVES; NEOPLASM RECURRENCE, LOCAL;

EID: 80051706635     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2011.02695.x     Document Type: Review

References (127)

1. Fegiz G, Ramacciato G, D'Angelo F et al. Patient selection and factors affecting results following resection for hepatic metastases from colorectal carcinoma. Int Surg 1991; 76: 58-63.
2. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995; 19: 59-71.
3. Bowel cancer statistics, 2007. (accessed September 2010).
4. Hugh TJ, Kinsella AR, Poston GJ. Management strategies for colorectal liver metastases - Part I. Surg Oncol 1997; 6: 19-30.
5. Ambiru S, Miyazaki M, Isono T et al. Hepatic resection for colorectal metastases: analysis of prognostic factors. Dis Colon Rectum 1999; 42: 632-9.
6. Bakalakos EA, Burak WE Jr, Young DC, Martin EW Jr. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases? Am J Surg 1999; 177: 2-6.
7. Choti MA, Sitzmann JV, Tiburi MF et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002; 235: 759-66.
8. Crowe PJ, Yang JL, Berney CR et al. Genetic markers of survival and liver recurrence after resection of liver metastases from colorectal cancer. World J Surg 2001; 25: 996-1001.
9. Figueras J, Valls C, Rafecas A et al. Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastases. Br J Surg 2001; 88: 980-5.
10. Mala T, Bohler G, Mathisen O, Bergan A, Soreide O. Hepatic resection for colorectal metastases: can preoperative scoring predict patient outcome? World J Surg 2002; 26: 1348-53.
11. Nordlinger B, Vaillant JC, Guiguet M et al. Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Francaise de Chirurgie. J Clin Oncol 1994; 12: 1491-6.
12. Rees M, Plant G, Bygrave S. Late results justify resection for multiple hepatic metastases from colorectal cancer. Br J Surg 1997; 84: 1136-40.
13. Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 1991; 110: 13-29.
14. Schlag P, Hohenberger P, Herfarth C. Resection of liver metastases in colorectal cancer - competitive analysis of treatment results in synchronous versus metachronous metastases. Eur J Surg Oncol 1990; 16: 360-5.
15. Wanebo HJ, Chu QD, Vezeridis MP, Soderberg C. Patient selection for hepatic resection of colorectal metastases. Arch Surg 1996; 131: 322-9.
16. Wang JY, Chiang JM, Jeng LB et al. Resection of liver metastases from colorectal cancer: are there any truly significant clinical prognosticators? Dis Colon Rectum 1996; 39: 847-51.
17. Yamada H, Kondo S, Okushiba S, Morikawa T, Katoh H. Analysis of predictive factors for recurrence after hepatectomy for colorectal liver metastases. World J Surg 2001; 25: 1129-33.
18. Adam R, Vinet E. Regional treatment of metastasis: surgery of colorectal liver metastases. Ann Oncol 2004; 15(Suppl. 4): iv103-6.
19. Garcea G, Ong SL, Maddern GJ. Inoperable colorectal liver metastases: a declining entity? Eur J Cancer 2008; 44: 2555-72.
20. Adam R, Wicherts DA, de Haas RJ et al. Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? J Clin Oncol 2009; 27: 1829-35.
21. Goldberg SN, Solbiati L, Hahn PF et al. Large-volume tissue ablation with radio frequency by using a clustered, internally cooled electrode technique: laboratory and clinical experience in liver metastases. Radiology 1998; 209: 371-9.
22. Liang P, Dong B, Yu X et al. Prognostic factors for percutaneous microwave coagulation therapy of hepatic metastases. AJR Am J Roentgenol 2003; 181: 1319-25.
23. Shen P, Geisinger KR, Zagoria R, Levine EA. Pathologic correlation study of microwave coagulation therapy for hepatic malignancies using a three-ring probe. J Gastrointest Surg 2007; 11: 603-11.
24. Jiao LR, Habib NA. Experimental study of large-volume microwave ablation in the liver (Br J Surg 2002; 89: 1003-7). Br J Surg 2003; 90: 122.
25. Sato M, Watanabe Y, Kashu Y et al. Sequential percutaneous microwave coagulation therapy for liver tumor. Am J Surg 1998; 175: 322-4.
26. Juni P, Holenstein F, Sterne J, Bartlett C, Egger M. Direction and impact of language bias in meta-analyses of controlled trials: empirical study. Int J Epidemiol 2002; 31: 115-23.
27. Jadad AR, Moore RA, Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
28. Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbe KA. Incorporating variations in the quality of individual randomized trials into meta-analysis. J Clin Epidemiol 1992; 45: 255-65.
29. Wong SL, Mangu PB, Choti MA et al. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol 2010; 28: 493-508.
30. Khatri VP, McGahan J. Non-resection approaches for colorectal liver metastases. Surg Clin North Am 2004; 84: 587-606.
31. Mala T, Samset E, Aurdal L et al. Magnetic resonance imaging-estimated three-dimensional temperature distribution in liver cryolesions: a study of cryolesion characteristics assumed necessary for tumor ablation. Cryobiology 2001; 43: 268-75.
32. Evans J. Ablative and catheter-delivered therapies for colorectal liver metastases (CRLM). Eur J Surg Oncol 2007; 33(Suppl. 2): S64-75.
33. Bhardwaj N, Strickland AD, Ahmad F et al. A comparative histological evaluation of the ablations produced by microwave, cryotherapy and radiofrequency in the liver. Pathology 2009; 41: 168-72.
34. Seifert JK, Morris DL. World survey on the complications of hepatic and prostate cryotherapy. World J Surg 1999; 23: 109-13.
35. Bhardwaj N, Strickland AD, Ahmad F, Dennison AR, Lloyd DM. Liver ablation techniques: a review. Surg Endosc 2010; 24: 254-65.
36. Primrose JN. Treatment of colorectal metastases: surgery, cryotherapy, or radiofrequency ablation. Gut 2002; 50: 1-5.
37. Seifert JK, Achenbach T, Heintz A, Bottger TC, Junginger T. Cryotherapy for liver metastases. Int J Colorectal Dis 2000; 15: 161-6.
38. Stubbs RS, Alwan MH, Booth MW. Hepatic cryotherapy and subsequent hepatic arterial chemotherapy for colorectal metastases to the liver. HPB Surg 1998; 11: 97-104.
39. Seifert JK, Junginger T, Morris DL. A collective review of the world literature on hepatic cryotherapy. J R Coll Surg Edinb 1998; 43: 141-54.
40. Korpan NN. Hepatic cryosurgery for liver metastases. Long-term follow-up. Ann Surg 1997; 225: 193-201.
41. Seifert JK, Morris DL. Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer. Ann Surg 1998; 228: 201-8.
42. Seifert JK, Morris DL. Cryotherapy of the resection edge after liver resection for colorectal cancer metastases. Aust N Z J Surg 1998; 68: 725-8.
43. Dwerryhouse SJ, Seifert JK, McCall JL et al. Hepatic resection with cryotherapy to involved or inadequate resection margin (edge freeze) for metastases from colorectal cancer. Br J Surg 1998; 85: 185-7.
44. Weaver ML, Ashton JG, Zemel R. Treatment of colorectal liver metastases by cryotherapy. Semin Surg Oncol 1998; 14: 163-70.
45. Seifert JK, Morris DL. Indicators of recurrence following cryotherapy for hepatic metastases from colorectal cancer. Br J Surg 1999; 86: 234-40.
46. Seifert JK, Morris DL. Low preoperative serum carcinoembryonic antigen concentration is a marker of good prognosis in patients undergoing cryotherapy for low volume hepatic metastases from colorectal cancer. Int J Surg Investig 2000; 2: 327-34.
47. Finlay IG, Seifert JK, Stewart GJ, Morris DL. Resection with cryotherapy of colorectal hepatic metastases has the same survival as hepatic resection alone. Eur J Surg Oncol 2000; 26: 199-202.
48. Gruenberger T, Jourdan JL, Zhao J, King J, Morris DL. Echogenicity of liver metastases is an independent prognostic factor after potentially curative treatment. Arch Surg 2000; 135: 1285-90.
49. Ruers T, Bleichrodt RP. Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer 2002; 38: 1023-33.
50. Sheen AJ, Poston GJ, Sherlock DJ. Cryotherapeutic ablation of liver tumours. Br J Surg 2002; 89: 1396-401.
51. Rivoire M, De Cian F, Meeus P et al. Combination of neoadjuvant chemotherapy with cryotherapy and surgical resection for the treatment of unresectable liver metastases from colorectal carcinoma. Cancer 2002; 95: 2283-92.
52. Yan DB, Clingan P, Morris DL. Hepatic cryotherapy and regional chemotherapy with or without resection for liver metastases from colorectal carcinoma: how many are too many? Cancer 2003; 98: 320-30.
53. Seifert JK, Junginger T. Prognostic factors for cryotherapy of colorectal liver metastases. Eur J Surg Oncol 2004; 30: 34-40.
54. Kerkar S, Carlin AM, Sohn RL et al. Long-term follow up and prognostic factors for cryotherapy of malignant liver tumors. Surgery 2004; 136: 770-9.
55. Mala T, Edwin B, Mathisen O et al. Cryoablation of colorectal liver metastases: minimally invasive tumour control. Scand J Gastroenterol 2004; 39: 571-8.
56. Brooks AJ, Wang F, Alfredson M, Yan TD, Morris DL. Synchronous liver resection and cryotherapy for colorectal metastases: survival analysis. Surgeon 2005; 3: 265-8.
57. Joosten J, Jager G, Oyen W, Wobbes T, Ruers T. Cryosurgery and radiofrequency ablation for unresectable colorectal liver metastases. Eur J Surg Oncol 2005; 31: 1152-9.
58. Seifert JK, Springer A, Baier P, Junginger T. Liver resection or cryotherapy for colorectal liver metastases: a prospective case control study. Int J Colorectal Dis 2005; 20: 507-20.
59. Chen YY, Perera DS, Yan TD, Schmidt LM, Morris DL. Applying Fong's CRS liver score in patients with colorectal liver metastases treated by cryotherapy. Asian J Surg 2006; 29: 238-41.
60. Niu R, Yan TD, Zhu JC et al. Recurrence and survival outcomes after hepatic resection with or without cryotherapy for liver metastases from colorectal carcinoma. Ann Surg Oncol 2007; 14: 2078-87.
61. Yan TD, Padang R, Morris DL. Longterm results and prognostic indicators after cryotherapy and hepatic arterial chemotherapy with or without resection for colorectal liver metastases in 224 patients: longterm survival can be achieved in patients with multiple bilateral liver metastases. J Am Coll Surg 2006; 202: 100-11.
62. Paganini AM, Rotundo A, Barchetti L, Lezoche E. Cryosurgical ablation of hepatic colorectal metastases. Surg Oncol 2007; 16(Suppl. 1): S137-40.
63. Bageacu S, Kaczmarek D, Lacroix M et al. Cryosurgery for resectable and unresectable hepatic metastases from colorectal cancer. Eur J Surg Oncol 2007; 33: 590-6.
64. Kornprat P, Jarnagin WR, DeMatteo RP et al. Role of intraoperative thermoablation combined with resection in the treatment of hepatic metastasis from colorectal cancer. Arch Surg 2007; 142: 1087-92.
65. Gruenberger T, Jourdan JL, Zhao J, King J, Morris DL. Reduction in recurrence risk for involved or inadequate margins with edge cryotherapy after liver resection for colorectal metastases. Arch Surg 2001; 136: 1154-7.
66. Livraghi T, Goldberg SN, Monti F et al. Saline-enhanced radio-frequency tissue ablation in the treatment of liver metastases. Radiology 1997; 202: 205-10.
67. Wright AS, Sampson LA, Warner TF, Mahvi DM, Lee FT Jr. Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology 2005; 236: 132-9.
68. Berber E, Siperstein A. Local recurrence after laparoscopic radiofrequency ablation of liver tumors: an analysis of 1032 tumors. Ann Surg Oncol 2008; 15: 2757-64.
69. Lermite E, Lebigot J, Oberti F et al. Radiofrequency thermal ablation of liver carcinoma. Prospective study of 82 lesions. Gastroenterol Clin Biol 2006; 30: 130-5.
70. Amersi FF, McElrath-Garza A, Ahmad A et al. Long-term survival after radiofrequency ablation of complex unresectable liver tumors. Arch Surg 2006; 141: 581-7; discussion 587-8.
71. Jiang HC, Liu LX, Piao DX et al. Clinical short-term results of radiofrequency ablation in liver cancers. World J Gastroenterol 2002; 8: 624-30.
72. Abitabile P, Hartl U, Lange J, Maurer CA. Radiofrequency ablation permits an effective treatment for colorectal liver metastasis. Eur J Surg Oncol 2007; 33: 67-71.
73. Gillams AR, Lees WR. Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 2004; 14: 2261-7.
74. Dodd GD 3rd, Frank MS, Aribandi M, Chopra S, Chintapalli KN. Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations. AJR Am J Roentgenol 2001; 177: 777-82.
75. Lu DS, Raman SS, Limanond P et al. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol 2003; 14: 1267-74.
76. Ruers T. Final results of the EORTC Intergroup randomized study 40004 (CLOCC) evaluting the benefit of radiofrequency ablation combined with chemotherapy for unresectable colorectal liver metastases. J Clin Oncol 2010; 15S(Suppl.): abst 3526.
77. de Baere T, Elias D, Dromain C et al. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1year. AJR Am J Roentgenol 2000; 175: 1619-25.
78. Elias D, Goharin A, El Otmany A et al. Usefulness of intraoperative radiofrequency thermoablation of liver tumours associated or not with hepatectomy. Eur J Surg Oncol 2000; 26: 763-9.
79. Chung MH, Ye W, Ramming KP, Bilchik AJ. Repeat hepatic cryotherapy for metastatic colorectal cancer. J Gastrointest Surg 2001; 5: 287-93.
80. Solbiati L, Ierace T, Tonolini M, Osti V, Cova L. Radiofrequency thermal ablation of hepatic metastases. Eur J Ultrasound 2001; 13: 149-58.
81. Stippel DL, Bohm S, Beckurts KT, Brochhagen HG, Holscher AH. Intraoperative radiofrequency ablation using a 3D navigation tool for treatment of colorectal liver metastases. Onkologie 2002; 25: 346-50.
82. Iannitti DA, Dupuy DE, Mayo-Smith WW, Murphy B. Hepatic radiofrequency ablation. Arch Surg 2002; 137: 422-6; discussion 427.
83. Cheng J, Glasgow RE, O'Rourke RW, Swanstrom LL, Hansen PD. Laparoscopic radiofrequency ablation and hepatic artery infusion pump placement in the evolving treatment of colorectal hepatic metastases. Surg Endosc 2003; 17: 61-7.
84. Oshowo A, Gillams A, Harrison E, Lees WR, Taylor I. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg 2003; 90: 1240-3.
85. Pawlik TM, Izzo F, Cohen DS, Morris JS, Curley SA. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol 2003; 10: 1059-69.
86. Scaife CL, Curley SA, Izzo F et al. Feasibility of adjuvant hepatic arterial infusion of chemotherapy after radiofrequency ablation with or without resection in patients with hepatic metastases from colorectal cancer. Ann Surg Oncol 2003; 10: 348-54.
87. Abdalla EK, Vauthey JN, Ellis LM et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239: 818-25.
88. Berber E, Pelley R, Siperstein AE. Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study. J Clin Oncol 2005; 23: 1358-64.
89. Elias D, Baton O, Sideris L et al. Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy to treat technically unresectable multiple colorectal liver metastases. J Surg Oncol 2005; 90: 36-42.
90. Gillams AR, Lees WR. Radiofrequency ablation of colorectal liver metastases. Abdom Imaging 2005; 30: 419-26.
91. Hildebrand P, Leibecke T, Kleemann M et al. Influence of operator experience in radiofrequency ablation of malignant liver tumours on treatment outcome. Eur J Surg Oncol 2006; 32: 430-4.
92. Aloia TA, Vauthey JN, Loyer EM et al. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 2006; 141: 460-6; discussion 466-7.
93. Suppiah A, White TJ, Roy-Choudhury SH et al. Long-term results of percutaneous radiofrequency ablation of unresectable colorectal hepatic metastases: final outcomes. Dig Surg 2007; 24: 358-60.
94. Siperstein AE, Berber E, Ballem N, Parikh RT. Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience. Ann Surg 2007; 246: 559-65.
95. Sorensen SM, Mortensen FV, Nielsen DT. Radiofrequency ablation of colorectal liver metastases: long-term survival. Acta Radiol 2007; 48: 253-8.
96. Terraz S, Constantin C, Majno PE, Spahr L, Mentha G, Becker CD. Image-guided multipolar radiofrequency ablation of liver tumours: initial clinical results. Eur Radiol 2007; 17: 2253-61.
97. Berber E, Tsinberg M, Tellioglu G, Simpfendorfer CH, Siperstein AE. Resection versus laparoscopic radiofrequency thermal ablation of solitary colorectal liver metastasis. J Gastrointest Surg 2008; 12: 1967-72.
98. Veltri A, Sacchetto P, Tosetti I, Pagano E, Fava C, Gandini G. Radiofrequency ablation of colorectal liver metastases: small size favorably predicts technique effectiveness and survival. Cardiovasc Intervent Radiol 2008; 31: 948-56.
99. Park IJ, Kim HC, Yu CS, Kim PN, Won HJ, Kim JC. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery. Ann Surg Oncol 2008; 15: 227-32.
100. Gleisner AL, Choti MA, Assumpcao L, Nathan H, Schulick RD, Pawlik TM. Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation. Arch Surg 2008; 143: 1204-12.
101. Lee WS, Yun SH, Chun HK et al. Clinical outcomes of hepatic resection and radiofrequency ablation in patients with solitary colorectal liver metastasis. J Clin Gastroenterol 2008; 42: 945-9.
102. Leblanc F, Fonck M, Brunet R, Becouarn Y, Mathoulin-Pelissier S, Evrard S. Comparison of hepatic recurrences after resection or intraoperative radiofrequency ablation indicated by size and topographical characteristics of the metastases. Eur J Surg Oncol 2008; 34: 185-90.
103. Eisele RM, Neumann U, Neuhaus P, Schumacher G. Open surgical is superior to percutaneous access for radiofrequency ablation of hepatic metastases. World J Surg 2009; 33: 804-11.
104. Reuter NP, Woodall CE, Scoggins CR, McMasters KM, Martin RC. Radiofrequency ablation vs. resection for hepatic colorectal metastasis: therapeutically equivalent? J Gastrointest Surg 2009; 13: 486-91.
105. Knudsen AR, Kannerup AS, Mortensen FV, Nielsen DT. Radiofrequency ablation of colorectal liver metastases downstaged by chemotherapy. Acta Radiol 2009; 50: 716-21.
106. Hur H, Ko YT, Min BS et al. Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases. Am J Surg 2009; 197: 728-36.
107. Nikfarjam M, Shereef S, Kimchi ET et al. Survival outcomes of patients with colorectal liver metastases following hepatic resection or ablation in the era of effective chemotherapy. Ann Surg Oncol 2009; 16: 1860-7.
108. Izzo F. Other thermal ablation techniques: microwave and interstitial laser ablation of liver tumors. Ann Surg Oncol 2003; 10: 491-7.
109. Wemyss-Holden SA, Dennison AR, Berry DP, Maddern GJ. Local ablation for unresectable liver tumors: is thermal best? J Hepatobiliary Pancreat Surg 2004; 11: 97-106.
110. Martin LW, Warren RS. Current management of colorectal liver metastases. Surg Oncol Clin N Am 2000; 9: 853-76.
111. Shibata T, Niinobu T, Ogata N. Comparison of the effects of in-vivo thermal ablation of pig liver by microwave and radiofrequency coagulation. J Hepatobiliary Pancreat Surg 2000; 7: 592-8.
112. Gravante G, Ong SL, Metcalfe MS, Strickland A, Dennison AR, Lloyd DM. Hepatic microwave ablation: a review of the histological changes following thermal damage. Liver Int 2008; 28: 911-21.
113. Ozaki T, Mori I, Nakamura M, Utsunomiya H, Tabuse K, Kakudo K. Microwave cell death: immunohistochemical and enzyme histochemical evaluation. Pathol Int 2003; 53: 686-92.
114. Seki T, Wakabayashi M, Nakagawa T et al. Percutaneous microwave coagulation therapy for solitary metastatic liver tumors from colorectal cancer: a pilot clinical study. Am J Gastroenterol 1999; 94: 322-7.
115. Shibata T, Niinobu T, Ogata N, Takami M. Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer 2000; 89: 276-84.
116. Tanaka K, Shimada H, Nagano Y, Endo I, Sekido H, Togo S. Outcome after hepatic resection versus combined resection and microwave ablation for multiple bilobar colorectal metastases to the liver. Surgery 2006; 139: 263-73.
117. Bhardwaj N, Strickland AD, Ahmad F et al. Microwave ablation for unresectable hepatic tumours: clinical results using a novel microwave probe and generator. Eur J Surg Oncol 2010; 36: 264-8.
118. Yokoyama T, Egami K, Miyamoto M et al. Percutaneous and laparoscopic approaches of radiofrequency ablation treatment for liver cancer. J Hepatobiliary Pancreat Surg 2003; 10: 425-7.
119. Kuang M, Lu MD, Xie XY et al. Liver cancer: increased microwave delivery to ablation zone with cooled-shaft antenna - experimental and clinical studies. Radiology 2007; 242: 914-24.
120. Iannitti DA, Martin RC, Simon CJ et al. Hepatic tumor ablation with clustered microwave antennae: the US Phase II Trial. HPB (Oxford) 2007; 9: 120-4.
121. Martin RC, Scoggins CR, McMasters KM. Microwave hepatic ablation: initial experience of safety and efficacy. J Surg Oncol 2007; 96: 481-6.
122. Zhang X, Chen B, Hu S et al. Microwave ablation with cooled-tip electrode for liver cancer: an analysis of 160 cases. Hepatogastroenterology 2008; 55: 2184-7.
123. Ogata Y, Uchida S, Hisaka T et al. Intraoperative thermal ablation therapy for small colorectal metastases to the liver. Hepatogastroenterology 2008; 55: 550-6.
124. Zhou P, Liang P, Yu X, Wang Y, Dong B. Percutaneous microwave ablation of liver cancer adjacent to the gastrointestinal tract. J Gastrointest Surg 2009; 13: 318-24.
125. Liang P, Wang Y, Yu X, Dong B. Malignant liver tumors: treatment with percutaneous microwave ablation - complications among cohort of 1136 patients. Radiology 2009; 251: 933-40.
126. Shibata T, Murakami T, Ogata N. Percutaneous microwave coagulation therapy for patients with primary and metastatic hepatic tumors during interruption of hepatic blood flow. Cancer 2000; 88: 302-11.
127. Elias D, Glehen O, Pocard M et al. A comparative study of complete cytoreductive surgery plus intraperitoneal chemotherapy to treat peritoneal dissemination from colon, rectum, small bowel, and nonpseudomyxoma appendix. Ann Surg 2010; 251: 896-901.